Stocks to Watch Wednesday: Nike, Lithium Americas, Arm, Occidental -- WSJ

Dow Jones
Oct 01

By WSJ Staff

Lithium Americas (LAC): The U.S. government said Tuesday it would take a 5% stake in both the Canadian company and its Nevada mining project. Shares jumped by roughly one-third in premarket trading.

Nike $(NKE)$: The retailer posted a surprise sales increase for last quarter, but raised its tariff-cost forecast to $1.5 billion this fiscal year. Shares climbed 3% ahead of the open.

Arm $(ARM)$: A U.S. court dismissed the chip designer's allegation that a Qualcomm $(QCOM)$ unit violated a licensing agreement. Arm shares fell around 2% before the bell.

Novo Nordisk (DK:NOVO.B), AstraZeneca (UK:AZN), Roche (CH:ROG): Shares of European drugmakers rose after President Trump unveiled plans for a direct-to-consumer website where Americans could buy discounted medicines. The news lifted U.S. pharmaceutical stocks Tuesday.

Occidental Petroleum $(OXY)$: Warren Buffett's Berkshire Hathaway $(BRK.B)$ is in talks to buy Occidental's petrochemical unit for around $10 billion. Occidental shares rose over 1% in premarket trading.

AES $(AES)$: BlackRock-owned Global Infrastructure Partners is nearing a $38 billion takeover of the utility group, according to a media report. AES shares shot up 14% premarket.

Acuity $(AYI)$, Cal-Maine Foods (CALM) and Conagra Brands $(CAG)$ are expected to report results before the bell.

This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).

(END) Dow Jones Newswires

October 01, 2025 05:05 ET (09:05 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10